Current Challenges of R/R MM Management and Innovation Updates
ASCO® 2023 Insights: "RedirecTT-1 Study Summary - Teclistamab + Talquetamab Targeting BCMA and GPRC5D in Patients With R/R MM"
By
ecancer
FEATURING
Yael C. Cohen
By
ecancer
FEATURING
Yael C. Cohen
Login to view comments.
Click here to Login
Current Challenges of R/R MM Management and Innovation Updates